Hema Mistry

2.7k total citations
90 papers, 1.7k citations indexed

About

Hema Mistry is a scholar working on Economics and Econometrics, Surgery and General Health Professions. According to data from OpenAlex, Hema Mistry has authored 90 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Economics and Econometrics, 18 papers in Surgery and 15 papers in General Health Professions. Recurrent topics in Hema Mistry's work include Health Systems, Economic Evaluations, Quality of Life (17 papers), Total Knee Arthroplasty Outcomes (13 papers) and Healthcare Policy and Management (11 papers). Hema Mistry is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (17 papers), Total Knee Arthroplasty Outcomes (13 papers) and Healthcare Policy and Management (11 papers). Hema Mistry collaborates with scholars based in United Kingdom, Australia and Austria. Hema Mistry's co-authors include Norman Waugh, Martin Connock, Pamela Royle, Rachel Court, Andrew Metcalfe, Aileen Clarke, D Shyangdan, Karoline Freeman, Alexander Tsertsvadze and Robin Dowie and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Hema Mistry

78 papers receiving 1.6k citations

Peers

Hema Mistry
Hsiao‐Yun Hu Taiwan
Benoît Arnould France
Paulo Ricardo Martins‐Filho Brazil
Gladys McPherson United Kingdom
Amalia Karahalios Australia
Santanu Datta United States
Shelley Selph United States
Amy W. Williams United States
Bin Ma China
Gail Tudor United States
Hsiao‐Yun Hu Taiwan
Hema Mistry
Citations per year, relative to Hema Mistry Hema Mistry (= 1×) peers Hsiao‐Yun Hu

Countries citing papers authored by Hema Mistry

Since Specialization
Citations

This map shows the geographic impact of Hema Mistry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hema Mistry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hema Mistry more than expected).

Fields of papers citing papers by Hema Mistry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hema Mistry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hema Mistry. The network helps show where Hema Mistry may publish in the future.

Co-authorship network of co-authors of Hema Mistry

This figure shows the co-authorship network connecting the top 25 collaborators of Hema Mistry. A scholar is included among the top collaborators of Hema Mistry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hema Mistry. Hema Mistry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Strongman, Helen, Sofia Eriksson, Michelle A. Miller, et al.. (2025). Validation of algorithms identifying diagnosed obstructive sleep apnoea and narcolepsy in coded primary care and linked hospital activity data in England. LSHTM Research Online (London School of Hygiene and Tropical Medicine). 5. 100110–100110.
3.
Uthman, Olalekan A., Lena Al-Khudairy, Chidozie Nduka, et al.. (2025). Determining optimal strategies for primary prevention of cardiovascular disease: a synopsis of an evidence synthesis study. Health Technology Assessment. 29(37). 1–18.
4.
5.
Underwood, Martin, et al.. (2024). Adverse and serious adverse events incidence of pharmacological interventions for managing chronic and episodic migraine in adults: a systematic review. BMJ Neurology Open. 6(1). e000616–e000616. 2 indexed citations
6.
Mistry, Hema, Sophie Rees, Jason Madan, et al.. (2024). Preventive drug treatments for adults with chronic migraine: a systematic review with economic modelling. Health Technology Assessment. 28(63). 1–329. 1 indexed citations
7.
Callander, Emily, Debra Bick, & Hema Mistry. (2023). Designing economic evaluations alongside clinical trials in maternal health care: A guide for clinical trial design. Birth. 51(2). 405–412. 1 indexed citations
8.
Uthman, Olalekan A., Lena Al-Khudairy, Chidozie Nduka, et al.. (2023). Interventions for primary prevention of cardiovascular disease: umbrella review of systematic reviews. Health Technology Assessment. 29(37). 1–26. 1 indexed citations
9.
Uthman, Olalekan A., Rachel Court, Seun Anjorin, et al.. (2023). The potential impact of policies and structural interventions in reducing cardiovascular disease and mortality: a systematic review of simulation-based studies. Health Technology Assessment. 29(37). 1–32. 4 indexed citations
10.
Shrestha, Sunil, et al.. (2023). Economic burden of chronic migraine in OECD countries: a systematic review. Health Economics Review. 13(1). 43–43. 8 indexed citations
11.
Nash, E.F., et al.. (2022). A prospective randomised controlled mixed-methods pilot study of home monitoring in adults with cystic fibrosis. Therapeutic Advances in Respiratory Disease. 16. 2663649461–2663649461. 12 indexed citations
12.
Uthman, Olalekan A., Rachel Court, Lena Al-Khudairy, et al.. (2022). Increasing comprehensiveness and reducing workload in a systematic review of complex interventions using automated machine learning. Health Technology Assessment. 29(37). 1–30. 3 indexed citations
13.
Mistry, Hema, Rachel Court, Lena Al-Khudairy, et al.. (2022). Determining optimal strategies for primary prevention of cardiovascular disease: systematic review of cost-effectiveness analyses in the United Kingdom. Health Technology Assessment. 29(37). 1–61. 2 indexed citations
14.
Lois, Noemi, Jonathan Cook, Ariel Wang, et al.. (2021). Multimodal imaging interpreted by graders to detect re-activation of diabetic eye disease in previously treated patients: the EMERALD diagnostic accuracy study. Health Technology Assessment. 25(32). 1–104. 2 indexed citations
15.
Uthman, Olalekan A., Lena Al-Khudairy, Chidozie Nduka, et al.. (2020). Determining optimal strategies for primary prevention of cardiovascular disease: systematic review, cost-effectiveness review and network meta-analysis protocol. Systematic Reviews. 9(1). 105–105. 9 indexed citations
16.
Lois, Noemi, Jonathan Cook, S J Aldington, et al.. (2019). Effectiveness of Multimodal imaging for the Evaluation of Retinal oedema And new vesseLs in Diabetic retinopathy (EMERALD). BMJ Open. 9(6). e027795–e027795. 4 indexed citations
17.
Mistry, Hema, Chidozie Nduka, Martin Connock, et al.. (2017). Venetoclax for Treating Chronic Lymphocytic Leukaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics. 36(4). 399–406. 7 indexed citations
18.
Lindenmeyer, Antje, Hema Mistry, Alice Sitch, et al.. (2016). Acute Kidney Outreach to Reduce Deterioration and Death (AKORDD) trial: the protocol for a large pilot study. BMJ Open. 6(8). e012253–e012253. 7 indexed citations
19.
Taylor‐Phillips, Sian, Hema Mistry, Daniel Todkill, et al.. (2015). Extending the diabetic retinopathy screening interval beyond 1 year: systematic review. British Journal of Ophthalmology. 100(1). 105–114. 58 indexed citations
20.
Mistry, Hema, Stephen Morris, Matthew Dyer, et al.. (2012). Cost-effectiveness of a European preventive cardiology programme in primary care: a Markov modelling approach. BMJ Open. 2(5). e001029–e001029. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hsiao‐Yun Hu Breakdown of academic impact, for papers by Benoît Arnould Breakdown of academic impact, for papers by Paulo Ricardo Martins‐Filho Breakdown of academic impact, for papers by Gladys McPherson Breakdown of academic impact, for papers by Amalia Karahalios Breakdown of academic impact, for papers by Santanu Datta Breakdown of academic impact, for papers by Shelley Selph Breakdown of academic impact, for papers by Amy W. Williams Breakdown of academic impact, for papers by Bin Ma Breakdown of academic impact, for papers by Gail Tudor
Rankless by CCL
2026